Ardelyx (ARDX) Assets (2013 - 2026)
Ardelyx posted quarterly Assets of $504.5 million for Q1 2026, up 22.99% year-on-year from $410.2 million in Q1 2025, and up 0.58% on a QoQ basis from $501.6 million in Q4 2025.
Ardelyx (ARDX) has 14 years of Assets data on file, last reported at $504.5 million in Q1 2026.
- For the quarter ending Q1 2026, Assets rose 22.99% year-over-year to $504.5 million; the trailing twelve-month figure through Mar 2026 stood at $504.5 million (up 22.99% YoY), and the FY2025 full-year result was $501.6 million, up 15.11% from the prior year.
- Assets for Q1 2026 stood at $504.5 million, up from $501.6 million in the prior quarter.
- Across five years, Assets topped out at $504.5 million in Q1 2026 and bottomed at $129.4 million in Q1 2022.
- The 5-year median for Assets is $342.4 million (2024), against an average of $321.7 million.
- The widest annual swing landed in 2022, when Assets sank 38.46%; it then soared 100.02% in 2023.
- A 5-year view of Assets shows it stood at $190.1 million in 2022, then jumped by 56.57% to $297.6 million in 2023, then jumped by 46.43% to $435.8 million in 2024, then climbed by 15.11% to $501.6 million in 2025, then rose by 0.58% to $504.5 million in 2026.
- The last three Assets figures came in at $504.5 million (Q1 2026), $501.6 million (Q4 2025), and $486.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 14.93 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 37.37 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 1.73 Bn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 78.88 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 33.89 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 26.48 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 23.64 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 40.87 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 5.13 Bn |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn | 504.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 504.51 Mn |
| Dec 31, 2025 | 501.60 Mn |
| Sep 30, 2025 | 486.17 Mn |
| Jun 30, 2025 | 466.77 Mn |
| Mar 31, 2025 | 410.19 Mn |
| Dec 31, 2024 | 435.75 Mn |
| Sep 30, 2024 | 367.86 Mn |
| Jun 30, 2024 | 343.49 Mn |
| Mar 31, 2024 | 342.38 Mn |
| Dec 31, 2023 | 297.58 Mn |
| Sep 30, 2023 | 289.38 Mn |
| Jun 30, 2023 | 211.20 Mn |
| Mar 31, 2023 | 217.02 Mn |
| Dec 31, 2022 | 190.07 Mn |
| Sep 30, 2022 | 144.67 Mn |
| Jun 30, 2022 | 131.61 Mn |
| Mar 31, 2022 | 129.41 Mn |
| Dec 31, 2021 | 149.91 Mn |
| Sep 30, 2021 | 170.85 Mn |
| Jun 30, 2021 | 204.98 Mn |
| Mar 31, 2021 | 210.29 Mn |
| Dec 31, 2020 | 201.56 Mn |
| Sep 30, 2020 | 198.56 Mn |
| Jun 30, 2020 | 217.34 Mn |
| Mar 31, 2020 | 235.32 Mn |
| Dec 31, 2019 | 259.78 Mn |
| Sep 30, 2019 | 119.41 Mn |
| Jun 30, 2019 | 137.98 Mn |
| Mar 31, 2019 | 166.14 Mn |
| Dec 31, 2018 | 183.33 Mn |
| Sep 30, 2018 | 206.67 Mn |
| Jun 30, 2018 | 228.54 Mn |
| Mar 31, 2018 | 142.84 Mn |
| Dec 31, 2017 | 157.90 Mn |
| Sep 30, 2017 | 143.11 Mn |
| Jun 30, 2017 | 164.12 Mn |
| Mar 31, 2017 | 187.77 Mn |
| Dec 31, 2016 | 213.13 Mn |
| Sep 30, 2016 | 241.32 Mn |
| Jun 30, 2016 | 155.38 Mn |
| Mar 31, 2016 | 180.50 Mn |
| Dec 31, 2015 | 116.95 Mn |
| Sep 30, 2015 | 138.07 Mn |
| Jun 30, 2015 | 148.19 Mn |
| Mar 31, 2015 | 105.40 Mn |
| Dec 31, 2014 | 113.41 Mn |
| Sep 30, 2014 | 117.73 Mn |
| Jun 30, 2014 | 123.48 Mn |
| Dec 31, 2013 | 42.90 Mn |